SHAREHOLDER ALERT: Weiss Law Investigates Aerie Pharmaceuticals, Inc.

NEW YORK, Aug. 23, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Aerie Pharmaceuticals, Inc. ("Aerie" or the "Company") (NASDAQ: AERI), in connection with the proposed acquisition of the Company by Alcon Inc. (NYSE: ALC).  Under the terms of the merger agreement, the Company's shareholders will receive $15.25 in cash for each share of Aerie common stock owned. The transaction is valued at approximately $770 million.

Read more at prnewswire.com